about
Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes.Expression of HLA class II-associated peptide transporter and proteasome genes in human placentas and trophoblast cell linesExon shuffling in vivo can generate novel HLA class I moleculesSequence and evolution of HLA-DR7- and -DRw53-associated beta-chain genesUbiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrinThe immunogenicity of a new human minor histocompatibility antigen results from differential antigen processingSingle MHC Mutation Eliminates Enthalpy Associated with T Cell Receptor BindingThe impact of human leukocyte antigen (HLA) micropolymorphism on ligand specificity within the HLA-B*41 allotypic familyFunctional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptorsThe SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes.Mutations in the alpha 2 helix of HLA-A2 affect presentation but do not inhibit binding of influenza virus matrix peptide.Recognition by xenogeneic cytotoxic T lymphocytes of cells expressing HLA-A2 or HLA-B7 after DNA-mediated gene transfer.Bypassing hybridoma technology: HLA-C reactive human single-chain antibody fragments (scFv) derived from a synthetic phage display library (HuCAL) and their potential to discriminate HLA class I specificities.Rapid and sensitive identification of major histocompatibility complex class I-associated tumor peptides by Nano-LC MALDI MS/MS.Chronic T cell lymphocytosis: a review of 21 cases.Role for intracellular proteases in the processing and transport of class II HLA antigens.Impaired cell surface expression of HLA-B antigens on mesenchymal stem cells and muscle cell progenitors.Expression of a single-chain HLA class I molecule in a human cell line: presentation of exogenous peptide and processed antigen to cytotoxic T lymphocytesPeptide-mediated modulation of T-cell allorecognition.Rhesus cytomegalovirus contains functional homologues of US2, US3, US6, and US11.p53 mutations in colorectal cancerRapid activation by interferon alpha of a latent DNA-binding protein present in the cytoplasm of untreated cellsThe HLA system: structure and function.Biochemical analysis of an antigen produced by both human sex chromosomesMeasurement of protein synthesis using heavy water labeling and peptide mass spectrometry: Discrimination between major histocompatibility complex allotypes.MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells.Immunohistochemical identification of macrophages, lymphoid cells and HLA antigens in the human testis.The bodies fight against cancer: is human leucocyte antigen (HLA) class 1 the key?Loss of HLA-A,B,C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia.Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans.ALLOREACTIVE T LYMPHOCYTES CULTURED FROM LIVER TRANSPLANT BIOPSIES: ASSOCIATIONS OF HLA SPECIFICITY WITH CLINICOPATHOLOGICAL FINDINGSFunctional characterization of infiltrating T lymphocytes in human hepatic allografts.Disorganisation of intermediate filament structure in alcoholic and other liver diseases.Childhood leukaemia and lymphoma: African experience supports a role for environmental factors in leukaemogenesisCloning of human thymic subcapsular cortex epithelial cells with T-lymphocyte binding sites and hemopoietic growth factor activityPrenatal exclusion of severe combined immunodeficiency.Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins.Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying theThe human myoglobin gene: a third dispersed globin locus in the human genome.Beta 2-microglobulin gene mutations: a study of established colorectal cell lines and fresh tumors
P2860
Q54795077-FC48D6E9-D25F-4E23-B0CC-914C8262A786Q54795078-CBFE98B1-5667-44A9-B114-DE9613C21173Q54795081-F7DEB22C-6A6F-46E2-AC56-CF795FFB2178Q54795083-2D934946-D9E9-4A5B-9C5C-D57B7A0D29EBQ54795085-98BAFFCA-2765-4DAD-8E2C-7040A108907BQ54795086-03F58E14-E271-4F36-9FEE-ACAB5E7CBD28Q54795089-35711FB8-3F95-4EF9-960B-2578FE30E681Q54795091-223895A8-8E9E-4889-93EE-EAB30997FA89Q54795152-1C5DF098-ECF0-495A-82C8-D97207C3D5A0Q54835722-D730CD0A-E79E-48B4-B668-250605CEBC72Q54937357-D74AE9FA-82A0-4082-8F68-84033E229560Q54937358-DB574295-D1F8-4E8D-9886-2478A81CF8C9
P1343
Q24339577-E775D085-EFF1-4894-B94C-120E97FFC625Q24541545-F99DBFC7-255F-4D31-8C94-9DF502A7F0F0Q24555794-85FE3EC2-DE1D-44F2-8F40-9AEB1735CE85Q24605083-D6409CCE-E01E-49F8-A7CD-F3C49543C868Q24634866-A38BDA8D-12F2-4924-BF52-1AE5F3B3684AQ24675797-87D5D8C6-B1C8-4A14-83EE-A18408BD11B9Q27647966-60372880-7AD2-436C-977A-18DC785D42FEQ27664962-5FE8098F-6910-4621-909E-22CA080A4E1BQ28199758-DF62CC93-EF2D-44DE-9B9D-67C1F6BFD455Q30176171-07453314-1753-4BD9-A88C-74D86E065658Q30442735-030F55AB-4EF1-4612-8F66-D58E39B974E9Q30449722-7538A9B8-D1CF-4EBF-9D5C-1D7F85BF87A5Q30910034-C8468903-724F-44A5-B23F-C4DDFB188B19Q33222048-BEC09AC9-7659-4B79-81DA-86B4189121D8Q33477144-E14B48AF-E29A-4ADD-8B76-55288B8F176FQ33578498-3D855F24-E235-47FB-A318-27F52628EDE4Q33598281-6D11F93A-A379-44B0-9BDE-364A9ABFFFB7Q33612515-1654327E-1426-4223-B582-6823E42676A8Q33664749-89DF5F39-A8D3-4C54-806B-18E1F74DCA37Q33755053-36B49055-6692-493F-9401-C47AB62C3B2AQ33818791-EC09AA59-E00C-4F79-8E27-C3DECF33F346Q33837271-CD5D5E37-8247-4706-A6A4-8336AB48A914Q33838173-FE2A4B4A-90DF-4891-A80A-055DC124FC63Q33931608-86F159DA-7C3E-4BCA-B680-4CC8B90969CDQ33959195-D69988D6-57ED-4943-A2EA-A11BAB6FBEC6Q34048911-FA1BFEEF-8E64-486C-9608-D4A58B1387C9Q34172799-42AFF27F-C4C2-4E2A-A1C0-31764248D060Q34199253-D296B8D7-84E0-4107-AA3C-E6488D10B433Q34292047-1E065507-3A51-432F-9BC1-3081EB62E76DQ34345458-7584A0F6-56EF-4859-B35E-25DA681D8F3BQ34396506-391DA4E2-00B2-447C-8530-4BCBE0D0B69AQ34420983-05248463-85D1-4346-9DD0-CE61110A1A58Q34529821-97823BC1-BA77-4848-AC09-B34661ED0239Q34550332-736385B0-C22F-4A7E-A18A-E3AB118C518AQ34640485-A66D6E12-820A-4D97-8A6C-68439CCF7878Q35116874-5CAE58F9-8877-4ABD-A394-BEAF275FE49DQ35203032-2DD49BA5-0F73-4739-B1DD-D5FA002535AEQ35209202-89A582B6-8049-4260-A60B-671F8EF6BD68Q35274323-FC9B33E1-DC86-4714-A561-81E2FDAF9FF2Q35282280-E9E6EF55-D9EE-48EB-9D5C-028EAF42C981
P2860
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
Monoclonal antibodies for analysis of the HLA system.
@en
Monoclonal antibodies for analysis of the HLA system.
@nl
type
label
Monoclonal antibodies for analysis of the HLA system.
@en
Monoclonal antibodies for analysis of the HLA system.
@nl
prefLabel
Monoclonal antibodies for analysis of the HLA system.
@en
Monoclonal antibodies for analysis of the HLA system.
@nl
P2093
P2860
P4510
P1476
Monoclonal antibodies for analysis of the HLA system.
@en
P2093
Barnstable CJ
Crumpton MJ
P2860
P356
10.1111/J.1600-065X.1979.TB00288.X
P577
1979-01-01T00:00:00Z